The three‑month outperformance (+0.8% vs -8.7% S&P) is the most striking, highlighting ACT's ability to generate positive returns when the broader market is in a pronounced downtrend, which could attract risk‑averse investors seeking relative safety.
While historical returns are strong, the stock’s forward trajectory could be jeopardized if earnings growth slows; a 10% deceleration in revenue CAGR would cut projected FY2026 EPS growth to below 5%, potentially compressing the price‑to‑earnings multiple by up to 15% and eroding the current valuation premium.
Despite insider buying, the overall institutional stake remains modest; a concentration of ownership under 25% means any sudden shift in sentiment could trigger outsized price moves, especially if large holders decide to reduce positions.
The 136% YoY revenue increase is the most striking driver, implying that Enact secured a large new client or completed a strategic acquisition, which could accelerate market share if integrated effectively.
The net margin of 54.8% leaves little room for error; a modest 5% decline in gross margin would cut net income by roughly $66 M (about 11% of EPS), highlighting sensitivity to pricing pressure or cost inflation.
The profit‑margin contraction of 2.7 percentage points (57.5% → 54.8%) is the dominant driver of ROE decline, signaling that operating profitability—rather than leverage—is under pressure and could limit future shareholder returns if not corrected.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 12.6 | 54.8 | 0.18 | 1.29 | 159.9 | 12.6 | 9.8 |
| 2024 | 13.8 | 57.2 | 0.18 | 1.31 | 161.8 | 13.7 | 10.5 |
| 2023 | 14.4 | 57.7 | 0.19 | 1.34 | 164.1 | 14.0 | 10.7 |
| 2022 | 17.2 | 64.3 | 0.19 | 1.40 | 247.5 | 16.2 | 12.3 |
| 2021 | 13.3 | 48.8 | 0.19 | 1.44 | 293.0 | 12.3 | 9.2 |
| 2020 | 9.5 | 33.5 | 0.19 | 1.47 | 335.4 | 8.8 | 6.5 |
| 2019 | 17.7 | 69.2 | 0.21 | 1.19 | 270.6 | 17.2 | 14.9 |
| 2018 | 14.8 | 57.5 | 0.21 | 1.25 | 16.7 | 11.8 |
The drop in asset turnover of roughly 14% (0.21 to 0.18) quantifies a slowdown in capital utilization; if this trend persists, ROIC could fall below the cost of capital, turning a current efficiency advantage into a potential value destroyer.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 2045 | 0 | 14 | 0 | 14 | |
| 2024 | 1989 | 0 | 16 | 3 | 0 | 16 |
| 2023 | 1967 | 0 | 14 | 4 | 0 | 14 |
| 2022 | 1912 | 0 | 14 | 5 | 0 | 14 |
| 2021 | 1927 | 0 | 14 | 5 | 0 | 14 |
| 2020 | 1880 | 0 | 15 | 0 | 15 | |
| 2019 | 1699 | 0 | 15 | 8 | 0 | 15 |
| 2018 | 1779 | 0 | 17 | 0 | 17 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $6893M | $1538M | $5355M | $744M | $162M | $582M | $629M | $92M |
| 2024 | $6550M | $1554M | $4996M | $760M | $161M | $599M | $652M | $119M |
| 2023 | $6218M | $1585M | $4632M | $769M | $153M | $616M | $661M | $153M |
| 2022 | $5736M | $1635M | $4101M | $771M | $257M | $514M | $556M | $206M |
| 2021 | $5914M | $1809M | $4106M | $776M | $350M | $426M | $468M | $246M |
| 2020 | $5698M | $1816M | $3882M | $776M | $323M | $453M | $499M | $358M |
| 2019 | $4555M | $728M | $3827M | $47M | $-538M | $585M | $626M | $383M |
| 2018 | $4099M | $825M | $3274M | $-159M | $159M | $199M | $422M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $725M | $-226M | $-515M | $725M | $-382M | $-121M | |
| 2024 | $686M | $-321M | $-382M | $686M | $-244M | $-112M | |
| 2023 | $632M | $-229M | $-301M | $632M | $-88M | $-213M | |
| 2022 | $561M | $-220M | $-252M | $7M | $567M | $-2M | $-251M |
| 2021 | $572M | $-399M | $-200M | $-686M | $-114M | $-200M | |
| 2020 | $704M | $-1137M | $300M | $704M | $-437M | ||
| 2019 | $500M | $176M | $-250M | $-176M | $324M | $-250M | |
| 2018 | $511M | $-498M | $-50M | $511M | $-50M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net